It is estimated that in the US alone, over twenty-five million individuals have their kidney or kidneys, progressed to at least Chronic Kidney Disease (CKD) Stage 3 (National Kidney Foundation, 2011). This number is alarmingly increasing each year while the age range of those with the said condition is getting wider. Needless to say, CKD is a worldwide medical problem, and that it requires a global effort especially efficient early detection and treatment of CKD (Levey et al., 2005).
In technical terms, CKD is a kidney damage wherein the glomerular filtration rate (GFR), which is the amount of blood
Continue reading...